← Back to Clinical Trials
Recruiting NCT06856330

NCT06856330 Effect of Furlow Palatoplasty With Buccal Myomucosal Flap on the Speech Development

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06856330
Status Recruiting
Phase —
Sponsor Fayoum University
Condition Cleft Palate
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-03-25
Primary Completion 2025-06-01

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 5 Years
Study Type OBSERVATIONAL
Interventions
furlow with buccal myomucosal flaptwo flap palatoplasty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2025-03-25 with a primary completion date of 2025-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

About 20 patient will be collected according to the eligibility criteria and grouped into Group I : 10 patients were treated with furlow with buccinators flap Group II : 10 patients were treated with 2 flap palatoplasty All patients will be examined by an expert Phoniatrician by Recording of speech samples in Arabic language for the children in a soundproof room including repeated syllables, sentences with high-pressure sounds and counting from 1 to 10. The records will be analyzed to assess the degree of hypernasality, speech intelligibility and compensatory speech errors

Eligibility Criteria

Inclusion Criteria: * 3-5 years old childreen with previous treated complete cleft lip and palate, nonsyndromic. * lip and palate repair performed by one craniofacial surgeon Exclusion Criteria: * Patients with syndromic cleft lip. * Redu cases * Bilateral cleft lip * Patient older 5years or younger 3 years. * Associated Cardiac anomalies. * Any systemic condition

Contact & Investigator

Central Contact

Shaimaa Refahee

✉ smr11@fayoum.edu.eg

📞 01227407987

Frequently Asked Questions

Who can join the NCT06856330 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 5 Years, studying Cleft Palate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06856330 currently recruiting?

Yes, NCT06856330 is actively recruiting participants. Contact the research team at smr11@fayoum.edu.eg for enrollment information.

Where is the NCT06856330 trial being conducted?

This trial is being conducted at Al Fayyum, Egypt.

Who is sponsoring the NCT06856330 clinical trial?

NCT06856330 is sponsored by Fayoum University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology